Baidu
map

进展

订阅

MedSci主页 / 所有栏目 / 进展

富血小板血浆在骨科中的应用研究进展（多篇文献）

2011-04-02 MedSci原创 MedSci原创

富血小板血浆骨科
关注

富血小板血浆加强治疗用于关节镜肩袖修复 　　在2011年2月15-19日召开的美国骨科医师学会年会（AAOS 2011）上，意大利Castracini等报告的一项研究显示，使用生长因子加强治疗在临床或结构上并不优于较传统的、技术水平要求不高的、经济学上更有优势的非加强缝合锚钉肩袖修复术。 　　修复术后肩袖恢复其肱骨插入位愈合的能力有限，而生长因子加强治疗似乎可增强这一过程的愈合。这项

富血小板血浆加强治疗用于关节镜肩袖修复 　　在2011年2月15-19日召开的美国骨科医师学会年会（AAOS 2011）上，意大利Castracini等报告的一项研究显示，使用生长因子加强治疗在临床或结构上并不优于较传统的、技术水平要求不高的、经济学上更有优势的非加强缝合锚钉肩袖修复术。 　　修复术后肩袖恢复其肱骨插入位愈合的能力有限，而生长因子加强治疗似乎可增强这一过程的愈合。这项随机对照研究旨在评估肩袖修复期间加用生长因子加强治疗的疗效和安全性。 　　81例肩袖撕裂的患者通过计算机生成序列被随机分配接受使用（n=43）或不使用（n=45）富血小板血浆加强治疗的关节镜肩袖修复术。研究主要终点是两组间自基线至16个月时Constant评分改变的差异。次要终点是MRI评价的经修复的肩袖的完整性。采用意向治疗分析。 　　所有患者均完成16个月随访。比较使用或不使用PRP的关节镜肩袖修复术可见，其总体Constant评分无统计学显著差异，MRI肌腱评分也无显著差异。 　　这项研究并不支持在肩袖修复时加用自体PRP来改善肩袖撕裂的愈合。 富血小板血浆用于NFL橄榄球员腘绳肌损伤 　　

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1811936, encodeId=e7ec1811936e6, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Tue Mar 06 13:03:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340354, encodeId=741113403543f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380313, encodeId=d1dc13803139b, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113, encodeId=ede121132c, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:42:00 CST 2011, time=2011-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112, encodeId=8dbe211239, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:41:00 CST 2011, time=2011-04-03, status=1, ipAttribution=)]
    2012-03-06 yankaienglish

    #血小板血浆#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1811936, encodeId=e7ec1811936e6, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Tue Mar 06 13:03:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340354, encodeId=741113403543f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380313, encodeId=d1dc13803139b, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113, encodeId=ede121132c, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:42:00 CST 2011, time=2011-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112, encodeId=8dbe211239, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:41:00 CST 2011, time=2011-04-03, status=1, ipAttribution=)]
    2011-04-04 ms7421025882867189

    #富血小板血浆#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1811936, encodeId=e7ec1811936e6, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Tue Mar 06 13:03:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340354, encodeId=741113403543f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380313, encodeId=d1dc13803139b, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113, encodeId=ede121132c, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:42:00 CST 2011, time=2011-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112, encodeId=8dbe211239, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:41:00 CST 2011, time=2011-04-03, status=1, ipAttribution=)]
    2011-04-04 mashirong

    #研究进展#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1811936, encodeId=e7ec1811936e6, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Tue Mar 06 13:03:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340354, encodeId=741113403543f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380313, encodeId=d1dc13803139b, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113, encodeId=ede121132c, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:42:00 CST 2011, time=2011-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112, encodeId=8dbe211239, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:41:00 CST 2011, time=2011-04-03, status=1, ipAttribution=)]
    2011-04-03 lovetcm

    这方面类似文章很多,可能会火三到四年

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1811936, encodeId=e7ec1811936e6, content=<a href='/topic/show?id=5ab78905623' target=_blank style='color:#2F92EE;'>#血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89056, encryptionId=5ab78905623, topicName=血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ebc122, createdName=yankaienglish, createdTime=Tue Mar 06 13:03:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340354, encodeId=741113403543f, content=<a href='/topic/show?id=26bd465e2e3' target=_blank style='color:#2F92EE;'>#富血小板血浆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46572, encryptionId=26bd465e2e3, topicName=富血小板血浆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c932500160, createdName=ms7421025882867189, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380313, encodeId=d1dc13803139b, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Mon Apr 04 13:03:00 CST 2011, time=2011-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113, encodeId=ede121132c, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:42:00 CST 2011, time=2011-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112, encodeId=8dbe211239, content=这方面类似文章很多,可能会火三到四年, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Apr 03 23:41:00 CST 2011, time=2011-04-03, status=1, ipAttribution=)]
    2011-04-03 lovetcm

    这方面类似文章很多,可能会火三到四年

    0

Baidu
map
Baidu
map
Baidu
map